Shareholders Equity: The sum of preferred and common equity items.
NanoViricides, Inc. (NNVC) had Shareholders Equity of $8.68M for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-8.22M |
|
-- |
|
-- |
|
$8.31M |
|
$-8.31M |
|
$0.09M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.31M |
|
$-7.78M |
|
20.19M |
|
20.19M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$3.16M |
|
$6.40M |
|
$6.71M |
|
$9.87M |
|
$1.19M |
|
-- |
|
-- |
|
$1.19M |
|
$8.68M |
|
$8.37M |
|
|
Shareholders Equity |
$8.68M |
23.01M |
|
| Cash Flow Statement Financials | |
$-7.70M |
|
$-0.08M |
|
$9.02M |
|
$1.56M |
|
$2.79M |
|
$1.24M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-94.65% |
|
-98.14% |
|
-83.24% |
|
-94.65% |
|
$0.38 |
|
$-0.39 |
|
$-0.38 |
|